{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:50:45Z","timestamp":1776300645860,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00520-016-3437-2","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T05:04:59Z","timestamp":1476680699000},"page":"549-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications"],"prefix":"10.1007","volume":"25","author":[{"given":"Stefan","family":"Stefanovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Wallwiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uros","family":"Karic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luka","family":"Katic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florin-Andrei","family":"Taran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Pesic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hartkopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peyman","family":"Hadji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Teufel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Brucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,17]]},"reference":[{"key":"3437_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-med-010713-141500","volume":"65","author":"E Basch","year":"2014","unstructured":"Basch E (2014) New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment. Annu Rev Med 65:307\u2013317. doi: 10.1146\/annurev-med-010713-141500","journal-title":"Annu Rev Med"},{"key":"3437_CR2","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration (2009) Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. In: Guid. Ind. patient-reported outcome Meas. Use Med. Prod. Dev. to Support Labeling Claims. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282"},{"key":"3437_CR3","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1200\/JCO.2008.18.5397","volume":"27","author":"WJ Gradishar","year":"2009","unstructured":"Gradishar WJ, Krasnojon D, Cheporov S et al (2009) Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer. J Clin Oncol 27:3611\u20133619. doi: 10.1200\/JCO.2008.18.5397","journal-title":"J Clin Oncol"},{"key":"3437_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","volume":"7","author":"E Basch","year":"2006","unstructured":"Basch E, Iasonos A, McDonough T et al (2006) Patient versus clinician symptom reporting using the National Cancer Institute common terminology criteria for adverse events: results of a questionnaire-based study. Lancet Oncol 7:903\u2013909. doi: 10.1016\/S1470-2045(06)70910-X","journal-title":"Lancet Oncol"},{"key":"3437_CR5","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/jnci\/djp386","volume":"101","author":"E Basch","year":"2009","unstructured":"Basch E, Jia X, Heller G et al (2009) Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst 101:1624\u20131632. doi: 10.1093\/jnci\/djp386","journal-title":"J Natl Cancer Inst"},{"key":"3437_CR6","first-page":"119","volume":"5","author":"LT Flores","year":"2012","unstructured":"Flores LT, Bennett AV, Law EB et al (2012) Patient-reported outcomes vs. clinician symptom reporting during chemoradiation for rectal cancer. Gastrointest Cancer Res 5:119\u2013124","journal-title":"Gastrointest Cancer Res"},{"key":"3437_CR7","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/jnci\/djr485","volume":"103","author":"C Quinten","year":"2011","unstructured":"Quinten C, Maringwa J, Gotay CC et al (2011) Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst 103:1851\u20131858. doi: 10.1093\/jnci\/djr485","journal-title":"J Natl Cancer Inst"},{"key":"3437_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.ijrobp.2007.12.030","volume":"71","author":"I Vistad","year":"2008","unstructured":"Vistad I, Cvancarova M, Foss\u00e5 SD, Kristensen GB (2008) Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians\u2019 assessments agree with those of their patients? Int J Radiat Oncol Biol Phys 71:1335\u20131342. doi: 10.1016\/j.ijrobp.2007.12.030","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3437_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/pon.1975","volume":"21","author":"A Werner","year":"2012","unstructured":"Werner A, Stenner C, Sch\u00fcz J (2012) Patient versus clinician symptom reporting: how accurate is the detection of distress in the oncologic after-care? Psychooncology 21:818\u2013826. doi: 10.1002\/pon.1975","journal-title":"Psychooncology"},{"key":"3437_CR10","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP) (2014) Reflection paper on the regulatory guidance for the use of healthrelated quality of life (HRQL) measures in the evaluation of medicinal products. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2014\/06\/WC500168852.pdf"},{"key":"3437_CR11","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/jnci\/djr493","volume":"103","author":"E Basch","year":"2011","unstructured":"Basch E, Bennett A, Pietanza MC (2011) Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events. JNCI J Natl Cancer Inst 103:1808\u20131810. doi: 10.1093\/jnci\/djr493","journal-title":"JNCI J Natl Cancer Inst"},{"key":"3437_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1056\/NEJMp0911494","volume":"362","author":"E Basch","year":"2010","unstructured":"Basch E (2010) The missing voice of patients in drug-safety reporting. N Engl J Med 362:865\u2013869. doi: 10.1056\/NEJMp0911494","journal-title":"N Engl J Med"},{"key":"3437_CR13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bmj.313.7056.530","volume":"313","author":"TC Egberts","year":"1996","unstructured":"Egberts TC, Smulders M, de Koning FH et al (1996) Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. BMJ 313:530\u2013531","journal-title":"BMJ"},{"key":"3437_CR14","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1200\/JCO.2012.47.6804","volume":"31","author":"TJ Judson","year":"2013","unstructured":"Judson TJ, Bennett AV, Rogak LJ et al (2013) Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol 31:2580\u20132585. doi: 10.1200\/JCO.2012.47.6804","journal-title":"J Clin Oncol"},{"key":"3437_CR15","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1200\/JCO.2007.11.2243","volume":"25","author":"E Basch","year":"2007","unstructured":"Basch E, Iasonos A, Barz A et al (2007) Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol 25:5374\u20135380. doi: 10.1200\/JCO.2007.11.2243","journal-title":"J Clin Oncol"},{"key":"3437_CR16","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.2196\/ijmr.2885","volume":"3","author":"NHI Hjollund","year":"2014","unstructured":"Hjollund NHI, Larsen LP, Biering K et al (2014) Use of patient-reported outcome (PRO) measures at group and patient levels: experiences from the generic integrated PRO system, WestChronic. Interact J Med Res 3:e5. doi: 10.2196\/ijmr.2885","journal-title":"Interact J Med Res"},{"key":"3437_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/pon.3087","volume":"22","author":"CF Snyder","year":"2013","unstructured":"Snyder CF, Blackford AL, Wolff AC et al (2013) Feasibility and value of PatientViewpoint: a web system for patient-reported outcomes assessment in clinical practice. Psychooncology 22:895\u2013901. doi: 10.1002\/pon.3087","journal-title":"Psychooncology"},{"key":"3437_CR18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/10826087609058800","volume":"11","author":"M Cohen","year":"1976","unstructured":"Cohen M, Howard A, Klein DF, Newfield K (1976) Evaluating outcome criteria used in methadone maintenance programs. Int J Addict 11:283\u2013294","journal-title":"Int J Addict"},{"key":"3437_CR19","first-page":"S580","volume":"8","author":"CR Dennison","year":"2002","unstructured":"Dennison CR (2002) The role of patient-reported outcomes in evaluating the quality of oncology care. Am J Manag Care 8:S580\u2013S586","journal-title":"Am J Manag Care"},{"key":"3437_CR20","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1200\/JCO.2005.04.275","volume":"23","author":"E Basch","year":"2005","unstructured":"Basch E, Artz D, Dulko D et al (2005) Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol 23:3552\u20133561. doi: 10.1200\/JCO.2005.04.275","journal-title":"J Clin Oncol"},{"key":"3437_CR21","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jpainsymman.2008.07.011","volume":"37","author":"AP Abernethy","year":"2009","unstructured":"Abernethy AP, Herndon JE, Wheeler JL et al (2009) Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e\/tablet data-collection system in academic oncology. J Pain Symptom Manag 37:1027\u20131038. doi: 10.1016\/j.jpainsymman.2008.07.011","journal-title":"J Pain Symptom Manag"},{"key":"3437_CR22","unstructured":"U.S. Department of Health and Human Services. National Institutes of Health. National Cancer Institute (2013) Patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). http:\/\/appliedresearch.cancer.gov\/pro-ctcae\/"},{"key":"3437_CR23","unstructured":"U.S. Department of Health and Human Services. National Institutes of Health. National Cancer Institute (2013) Patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Applied Research Program. http:\/\/appliedresearch.cancer.gov\/pro-ctcae\/pro-ctcae_fact_sheet.pdf"},{"key":"3437_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10549-011-1378-5","volume":"128","author":"A Oberguggenberger","year":"2011","unstructured":"Oberguggenberger A, Hubalek M, Sztankay M et al (2011) Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs. Breast Cancer Res Treat 128:553\u2013561. doi: 10.1007\/s10549-011-1378-5","journal-title":"Breast Cancer Res Treat"},{"key":"3437_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10552-012-0142-4","volume":"24","author":"SA Gho","year":"2013","unstructured":"Gho SA, Steele JR, Jones SC, Munro BJ (2013) Self-reported side effects of breast cancer treatment: a cross-sectional study of incidence, associations, and the influence of exercise. Cancer Causes Control 24:517\u2013528. doi: 10.1007\/s10552-012-0142-4","journal-title":"Cancer Causes Control"},{"key":"3437_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.breast.2004.02.009","volume":"13","author":"KM Malinovszky","year":"2004","unstructured":"Malinovszky KM, Cameron D, Douglas S et al (2004) Breast cancer patients\u2019 experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET. Breast 13:363\u2013368. doi: 10.1016\/j.breast.2004.02.009","journal-title":"Breast"},{"key":"3437_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000195540","volume":"76","author":"T Ruhstaller","year":"2009","unstructured":"Ruhstaller T, von Moos R, Rufibach K et al (2009) Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study. Oncology 76:142\u2013148. doi: 10.1159\/000195540","journal-title":"Oncology"},{"key":"3437_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/annonc\/mdl030","volume":"17","author":"A Glaus","year":"2006","unstructured":"Glaus A, Boehme C, Th\u00fcrlimann B et al (2006) Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Ann Oncol 17:801\u2013806. doi: 10.1093\/annonc\/mdl030","journal-title":"Ann Oncol"},{"key":"3437_CR29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1010684903199","volume":"66","author":"D Fellowes","year":"2001","unstructured":"Fellowes D, Fallowfield LJ, Saunders CM, Houghton J (2001) Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for \u201cwell-tolerated\u201d treatments? Breast Cancer Res Treat 66:73\u201381","journal-title":"Breast Cancer Res Treat"},{"key":"3437_CR30","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00520-007-0258-3","volume":"15","author":"K Ribi","year":"2007","unstructured":"Ribi K, Bernhard J, Rufibach K et al (2007) Endocrine symptom assessment in women with breast cancer: what a simple \u201cyes\u201d means. Support Care Cancer 15:1349\u20131356. doi: 10.1007\/s00520-007-0258-3","journal-title":"Support Care Cancer"},{"key":"3437_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3816\/CBC.2009.n.020","volume":"9","author":"SN Chin","year":"2009","unstructured":"Chin SN, Trinkaus M, Simmons C et al (2009) Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer. Clin Breast Cancer 9:108\u2013117. doi: 10.3816\/CBC.2009.n.020","journal-title":"Clin Breast Cancer"},{"key":"3437_CR32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1006263818115","volume":"55","author":"LJ Fallowfield","year":"1999","unstructured":"Fallowfield LJ, Leaity SK, Howell A et al (1999) Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 55:189\u2013199","journal-title":"Breast Cancer Res Treat"},{"key":"3437_CR33","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO.1999.17.5.1488","volume":"17","author":"JE Mortimer","year":"1999","unstructured":"Mortimer JE, Boucher L, Baty J et al (1999) Effect of tamoxifen on sexual functioning in patients with breast cancer. J Clin Oncol 17:1488\u20131492","journal-title":"J Clin Oncol"},{"key":"3437_CR34","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/cncr.27474","volume":"118","author":"KH Schmitz","year":"2012","unstructured":"Schmitz KH, Speck RM, Rye SA et al (2012) Prevalence of breast cancer treatment sequelae over 6\u00a0years of follow-up: the pulling through study. Cancer 118:2217\u20132225. doi: 10.1002\/cncr.27474","journal-title":"Cancer"},{"key":"3437_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/13697137.2012.688078","volume":"16","author":"B Ayers","year":"2013","unstructured":"Ayers B, Hunter MS (2013) Health-related quality of life of women with menopausal hot flushes and night sweats. Climacteric 16:235\u2013239. doi: 10.3109\/13697137.2012.688078","journal-title":"Climacteric"},{"key":"3437_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3109\/13697130903291058","volume":"13","author":"M Kontos","year":"2010","unstructured":"Kontos M, Agbaje OF, Rymer J, Fentiman IS (2010) What can be done about hot flushes after treatment for breast cancer? Climacteric 13:4\u201321. doi: 10.3109\/13697130903291058","journal-title":"Climacteric"},{"key":"3437_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/13697131003717070","volume":"14","author":"KL Rand","year":"2011","unstructured":"Rand KL, Otte JL, Flockhart D et al (2011) Modeling hot flushes and quality of life in breast cancer survivors. Climacteric 14:171\u2013180. doi: 10.3109\/13697131003717070","journal-title":"Climacteric"},{"key":"3437_CR38","doi-asserted-by":"publisher","unstructured":"Utian WH (2005) Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes 3. doi: 10.1186\/1477-7525-3-47","DOI":"10.1186\/1477-7525-3-47"},{"key":"3437_CR39","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3109\/09513590.2011.652717","volume":"28","author":"L Del Pup","year":"2012","unstructured":"Del Pup L (2012) Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients. Gynecol Endocrinol 28:740\u2013745. doi: 10.3109\/09513590.2011.652717","journal-title":"Gynecol Endocrinol"},{"key":"3437_CR40","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1097\/AOG.0000000000000283","volume":"123","author":"MF Goetsch","year":"2014","unstructured":"Goetsch MF, Lim JY, Caughey AB (2014) Locating pain in breast cancer survivors experiencing dyspareunia: a randomized controlled trial. Obstet Gynecol 123:1231\u20131236. doi: 10.1097\/AOG.0000000000000283","journal-title":"Obstet Gynecol"},{"key":"3437_CR41","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1080\/00224499.2014.928663","volume":"52","author":"SI McClelland","year":"2015","unstructured":"McClelland SI, Holland KJ, Griggs JJ (2015) Vaginal dryness and beyond: the sexual health needs of women diagnosed with metastatic breast cancer. J Sex Res 52:604\u2013616. doi: 10.1080\/00224499.2014.928663","journal-title":"J Sex Res"},{"key":"3437_CR42","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1001\/jama.298.17.2028","volume":"298","author":"KM Flegal","year":"2007","unstructured":"Flegal KM, Graubard BI, Williamson DF, Gail MH (2007) Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298:2028\u20132037. doi: 10.1001\/jama.298.17.2028","journal-title":"JAMA"},{"key":"3437_CR43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF03404221","volume":"103","author":"PT Katzmarzyk","year":"2012","unstructured":"Katzmarzyk PT, Reeder BA, Elliott S et al (2012) Body mass index and risk of cardiovascular disease, cancer and all-cause mortality. Can J Public Health 103:147\u2013151","journal-title":"Can J Public Health"},{"key":"3437_CR44","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1136\/heartjnl-2014-305816","volume":"100","author":"PK Myint","year":"2014","unstructured":"Myint PK, Kwok CS, Luben RN et al (2014) Body fat percentage, body mass index and waist-to-hip ratio as predictors of mortality and cardiovascular disease. Heart 100:1613\u20131619. doi: 10.1136\/heartjnl-2014-305816","journal-title":"Heart"},{"key":"3437_CR45","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/ejcn.2011.145","volume":"66","author":"X Song","year":"2012","unstructured":"Song X, Pitk\u00e4niemi J, Gao W et al (2012) Relationship between body mass index and mortality among Europeans. Eur J Clin Nutr 66:156\u2013165. doi: 10.1038\/ejcn.2011.145","journal-title":"Eur J Clin Nutr"},{"key":"3437_CR46","unstructured":"World Health Organization (2007) Fact sheet No. 310. The top ten causes of death. http:\/\/www.who.int\/mediacentre\/factsheets\/fs310.pdf"},{"key":"3437_CR47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1467-789X.2001.00040.x","volume":"2","author":"RL Kolotkin","year":"2001","unstructured":"Kolotkin RL, Meter K, Williams GR (2001) Quality of life and obesity. Obes Rev 2:219\u2013229","journal-title":"Obes Rev"},{"key":"3437_CR48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s11136-009-9497-8","volume":"18","author":"CF Snyder","year":"2009","unstructured":"Snyder CF, Jensen R, Courtin SO, Wu AW (2009) PatientViewpoint: a website for patient-reported outcomes assessment. Qual Life Res 18:793\u2013800. doi: 10.1007\/s11136-009-9497-8","journal-title":"Qual Life Res"},{"key":"3437_CR49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21091\/mppa.2012.1004","volume":"27","author":"S Schmalenberger","year":"2012","unstructured":"Schmalenberger S, Gessert CE, Giebenhain JE, Starr LD (2012) Livelihood vs. life: the occupational well-being of women musician survivors of breast cancer. Med Probl Perform Art 27:15\u201320","journal-title":"Med Probl Perform Art"},{"key":"3437_CR50","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/cncr.24924","volume":"116","author":"L Burhansstipanov","year":"2010","unstructured":"Burhansstipanov L, Krebs LU, Seals BF et al (2010) Native American breast cancer survivors\u2019 physical conditions and quality of life. Cancer 116:1560\u20131571. doi: 10.1002\/cncr.24924","journal-title":"Cancer"},{"key":"3437_CR51","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1200\/JCO.2012.42.5967","volume":"30","author":"E Basch","year":"2012","unstructured":"Basch E, Abernethy AP, Mullins CD et al (2012) Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol 30:4249\u20134255. doi: 10.1200\/JCO.2012.42.5967","journal-title":"J Clin Oncol"},{"key":"3437_CR52","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1055\/s-0032-1333301","volume":"63","author":"N Sch\u00e4ffeler","year":"2013","unstructured":"Sch\u00e4ffeler N, Pfeiffer K, Grischke EM et al (2013) Acceptance and reliability of an electronic psychooncological screening of patients with breast cancer: a randomized controlled study. Psychother Psychosom Med Psychol 63:374\u2013380. doi: 10.1055\/s-0032-1333301","journal-title":"Psychother Psychosom Med Psychol"},{"key":"3437_CR53","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11136-011-0031-4","volume":"21","author":"TM Atkinson","year":"2012","unstructured":"Atkinson TM, Li Y, Coffey CW et al (2012) Reliability of adverse symptom event reporting by clinicians. Qual Life Res 21:1159\u20131164. doi: 10.1007\/s11136-011-0031-4","journal-title":"Qual Life Res"},{"key":"3437_CR54","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.2196\/jmir.3421","volume":"16","author":"YH Min","year":"2014","unstructured":"Min YH, Lee JW, Shin Y-W et al (2014) Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study. J Med Internet Res 16:e135. doi: 10.2196\/jmir.3421","journal-title":"J Med Internet Res"},{"key":"3437_CR55","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/tmj.2012.0136","volume":"19","author":"KY-L Yap","year":"2013","unstructured":"Yap KY-L, Low HX, Koh KS et al (2013) Feasibility and acceptance of a pharmacist-run tele-oncology service for chemotherapy-induced nausea and vomiting in ambulatory cancer patients. Telemed J E Health 19:387\u2013395. doi: 10.1089\/tmj.2012.0136","journal-title":"Telemed J E Health"},{"key":"3437_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1258\/mi.2007.007034","volume":"14","author":"GL Jones","year":"2008","unstructured":"Jones GL, Sutton A (2008) Quality of life in obese postmenopausal women. Menopause Int 14:26\u201332. doi: 10.1258\/mi.2007.007034","journal-title":"Menopause Int"},{"key":"3437_CR57","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/bimj.19760180811","volume":"18","author":"AJ Gross","year":"1976","unstructured":"Gross AJ, Clark V (1976) Survival distributions, reliability applications in the biomedical. Sciences 18:671. doi: 10.1002\/bimj.19760180811","journal-title":"Sciences"},{"key":"3437_CR58","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","volume":"1","author":"AC Dueck","year":"2015","unstructured":"Dueck AC, Mendoza TR, Mitchell SA et al (2015) Validity and reliability of the US National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE. JAMA Oncol 1:1051\u20131059. doi: 10.1001\/jamaoncol.2015.2639","journal-title":"JAMA Oncol"},{"key":"3437_CR59","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10549-010-0802-6","volume":"124","author":"S HI","year":"2010","unstructured":"HI S, Sammel MD, Springer E et al (2010) Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors. Breast Cancer Res Treat 124:205\u2013211. doi: 10.1007\/s10549-010-0802-6","journal-title":"Breast Cancer Res Treat"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-016-3437-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T18:00:48Z","timestamp":1601143248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-016-3437-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,17]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3437"],"URL":"https:\/\/doi.org\/10.1007\/s00520-016-3437-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,17]]}}}